Cargando…
Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected the global population, with People Living with HIV (PLWH) being particularly vulnerable due to their compromised immune systems. Although vaccination is a crucial preventative measure against the severe acute res...
Autores principales: | Lan, Xinquan, Su, Bin, Liang, Shijie, Yu, Maohe, Qiao, Ying, Wang, Li, Song, Moxin, Wang, Yuxiao, Xu, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480566/ https://www.ncbi.nlm.nih.gov/pubmed/37680268 http://dx.doi.org/10.3389/fpubh.2023.1227277 |
Ejemplares similares
-
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
por: Wang, Yuxiao, et al.
Publicado: (2023) -
The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies
por: Xu, Junjie, et al.
Publicado: (2023) -
Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey — Four PLADs, China, 2022
por: Wang, Yuxiao, et al.
Publicado: (2023) -
Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy
por: Della Polla, Giorgia, et al.
Publicado: (2022) -
Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022
por: Zhang, Fan, et al.
Publicado: (2023)